de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Buchkapitel

In Vivo Quantitative Proteomics: The SILAC Mouse

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons78917

Zanivan,  Sara
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons78356

Mann,  Matthias
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Zanivan, S., Krueger, M., & Mann, M. (2011). In Vivo Quantitative Proteomics: The SILAC Mouse. In Method in Molecular Biology; Vol. 757 (Chapter 25, pp. 435-450). HUMANA PRESS INC.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-000E-CADE-8
Zusammenfassung
Mass spectrometry-based proteomics is a field that has been quickly developing, enabling increasingly giving in-depth characterization of the proteomes of cells and tissues. Current technology allows identifying thousands of proteins in a single experiment. Stable isotope labeling with amino acid in cell culture (SILAC) was originally developed for high accuracy quantitative proteomic studies in cell lines. We have shown that SILAC can be extended to in vivo animal model by fully labeling C57BL/6 mice with C-13(6)-Lysine (Lys6). We used SILAC mice technology to map quantitative proteomic changes in mice lacking the expression of beta 1 integrin, beta-Parvin, or the integrin tail-binding protein Kindlin-3. This approach confirmed the absence of the proteins and revealed a role of Kindlin-3 in red blood cells. Here we describe a practical method to generate and maintain a colony of SILAC mice and optimal strategies to perform in vivo quantitative proteomic experiments.